Cargando…

EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice

Background: EphrinA1-Fc abolishes acute I/R injury and attenuates nonreperfused cardiac injury 4 days after permanent occlusion in mice. The goal of this study was to assess the capacity of a single intramyocardial administration of ephrinA1-Fc at the time of coronary artery ligation, to determine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitehurst, K’Shylah S., Chan, Victoria A., Estes, Heather K., Valsaraj, Smrithi, Kent, Susan, Sharma, Uma M., Chase, R. Christopher, Bhuiyan, Maliha, Virag, Jitka A. I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461052/
https://www.ncbi.nlm.nih.gov/pubmed/32823610
http://dx.doi.org/10.3390/ijms21165811
_version_ 1783576710896156672
author Whitehurst, K’Shylah S.
Chan, Victoria A.
Estes, Heather K.
Valsaraj, Smrithi
Kent, Susan
Sharma, Uma M.
Chase, R. Christopher
Bhuiyan, Maliha
Virag, Jitka A. I.
author_facet Whitehurst, K’Shylah S.
Chan, Victoria A.
Estes, Heather K.
Valsaraj, Smrithi
Kent, Susan
Sharma, Uma M.
Chase, R. Christopher
Bhuiyan, Maliha
Virag, Jitka A. I.
author_sort Whitehurst, K’Shylah S.
collection PubMed
description Background: EphrinA1-Fc abolishes acute I/R injury and attenuates nonreperfused cardiac injury 4 days after permanent occlusion in mice. The goal of this study was to assess the capacity of a single intramyocardial administration of ephrinA1-Fc at the time of coronary artery ligation, to determine the degree to which early salvage effects translate to reduced adverse remodeling after 4 weeks of nonreperfused myocardial infarction (MI) in wild-type B6 and EphA2-R-M (EphA2 receptor null) mice. Methods: At 4 weeks post-MI, echocardiography, histologic and immunohistochemical analyses of B6 mouse hearts were performed. Primary mouse cardiac fibroblasts (FBs) isolated from B6 mice cultured in the presence of low and high dose ephrinA1-Fc, both with and without pro-fibrotic TGF-β stimulation and Western blots, were probed for relative expression of remodeling proteins MMP-2, MMP-9 and TIMP-1, in addition to DDR2 and (p)SMAD2/3/totalSMAD2/3. Results: EphrinA1-Fc preserved a significant degree of contractile function, decreased adverse left ventricular remodeling, attenuated excessive compensatory hypertrophy, and decreased interstitial fibrosis in wild-type (WT) B6 mouse hearts. In contrast, most of these parameters were poorer in ephrinA1-Fc-treated EphA2-R-M mice. Of note, fibrosis was proportionately decreased, implying that other EphA receptor(s) are more important in regulating the pro-fibrotic response. Primary FBs showed disparate alteration of MMP-2, MMP-9 and TIMP-1, as well as DDR2 and p-SMAD2/3/totalSMAD2/3, which indicates that matrix remodeling and cardiac fibrosis in the injured heart are influenced by ephrinA1-Fc. Conclusion: This study demonstrates the capacity of a single administration of ephrinA1-Fc at the onset of injury to attenuate long-term nonreperfused post-MI ventricular remodeling that results in progressive heart failure, and the important role of EphA2 in mitigating the deleterious effects.
format Online
Article
Text
id pubmed-7461052
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74610522020-09-14 EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice Whitehurst, K’Shylah S. Chan, Victoria A. Estes, Heather K. Valsaraj, Smrithi Kent, Susan Sharma, Uma M. Chase, R. Christopher Bhuiyan, Maliha Virag, Jitka A. I. Int J Mol Sci Article Background: EphrinA1-Fc abolishes acute I/R injury and attenuates nonreperfused cardiac injury 4 days after permanent occlusion in mice. The goal of this study was to assess the capacity of a single intramyocardial administration of ephrinA1-Fc at the time of coronary artery ligation, to determine the degree to which early salvage effects translate to reduced adverse remodeling after 4 weeks of nonreperfused myocardial infarction (MI) in wild-type B6 and EphA2-R-M (EphA2 receptor null) mice. Methods: At 4 weeks post-MI, echocardiography, histologic and immunohistochemical analyses of B6 mouse hearts were performed. Primary mouse cardiac fibroblasts (FBs) isolated from B6 mice cultured in the presence of low and high dose ephrinA1-Fc, both with and without pro-fibrotic TGF-β stimulation and Western blots, were probed for relative expression of remodeling proteins MMP-2, MMP-9 and TIMP-1, in addition to DDR2 and (p)SMAD2/3/totalSMAD2/3. Results: EphrinA1-Fc preserved a significant degree of contractile function, decreased adverse left ventricular remodeling, attenuated excessive compensatory hypertrophy, and decreased interstitial fibrosis in wild-type (WT) B6 mouse hearts. In contrast, most of these parameters were poorer in ephrinA1-Fc-treated EphA2-R-M mice. Of note, fibrosis was proportionately decreased, implying that other EphA receptor(s) are more important in regulating the pro-fibrotic response. Primary FBs showed disparate alteration of MMP-2, MMP-9 and TIMP-1, as well as DDR2 and p-SMAD2/3/totalSMAD2/3, which indicates that matrix remodeling and cardiac fibrosis in the injured heart are influenced by ephrinA1-Fc. Conclusion: This study demonstrates the capacity of a single administration of ephrinA1-Fc at the onset of injury to attenuate long-term nonreperfused post-MI ventricular remodeling that results in progressive heart failure, and the important role of EphA2 in mitigating the deleterious effects. MDPI 2020-08-13 /pmc/articles/PMC7461052/ /pubmed/32823610 http://dx.doi.org/10.3390/ijms21165811 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Whitehurst, K’Shylah S.
Chan, Victoria A.
Estes, Heather K.
Valsaraj, Smrithi
Kent, Susan
Sharma, Uma M.
Chase, R. Christopher
Bhuiyan, Maliha
Virag, Jitka A. I.
EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice
title EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice
title_full EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice
title_fullStr EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice
title_full_unstemmed EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice
title_short EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice
title_sort ephrina1-fc attenuates ventricular remodeling and dysfunction in chronically nonreperfused wt but not epha2-r-m mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461052/
https://www.ncbi.nlm.nih.gov/pubmed/32823610
http://dx.doi.org/10.3390/ijms21165811
work_keys_str_mv AT whitehurstkshylahs ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice
AT chanvictoriaa ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice
AT estesheatherk ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice
AT valsarajsmrithi ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice
AT kentsusan ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice
AT sharmaumam ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice
AT chaserchristopher ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice
AT bhuiyanmaliha ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice
AT viragjitkaai ephrina1fcattenuatesventricularremodelinganddysfunctioninchronicallynonreperfusedwtbutnotepha2rmmice